Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) today announced a plan to open its Asia Operations Center in Taipei, Taiwan. This new center will...
CytoPharm, Inc. and Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced positive clinical findings from a dose-ranging, Phase 2 clinical trial...
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that Dr. Stephen T. Chen has been appointed as Chairman of the Board and Chief Executive...
Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) announced today that a new audio interview with ChartPoppers.com is now available (AMAR). ABI is...
Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) today provided an update on company activities. Oral Interferon Phase 2 Hepatitis C Study Nearing...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.